Advantage Austria is the Foreign Trade Development Agency au Austria
MedNest has designed and operated a 3 year comprehensive program to develop and activate Austrian Medical Technology Mid-size companies in the US, including Educational Conferences in throughout Austria, case-study centric workshops and business development programs in the USA.
The goal of the New York Stem Cell Foundation is to concentrate on translational "bench to bedside" research that will advance the search for cures of the major diseases of our time. The Foundation's research will be conducted in consultation with its New York institutional partners, as well as Johns Hopkins, Harvard University, Columbia University, and our internationally renowned Medical Advisory Board
MedNest is a contributor to the Foundation as a way to share its passion for groundbreaking science and international partnerships.
DermaNest brings breakthrough Skin Diagnostics and Therapeutics to enable Personalized Cosmetics Solutions for the US Markets.
Focus on Health Business Challenge - New Zealand Trade and Enterprise
Overview: MedNest teams up with the New Zealand Trade and Enterprise and sponsors the "Focus on Health Business Development Challenge". This program aims to introduce some of New Zealandís most innovative and commercially viable health solutions into the US healthcare system. The competition gives participants the chance to be connected to a network of influential health and business professionals in the United States and New Zealand, including investors, partners and buyers. The Focus on Health Challenge has been developed by New Zealand Trade and Enterprise, the New Zealand government's national economic development agency.
German American Chamber of Commerce
Overview: For sixty years the German American Chamber of Commerceģ, New York has promoted bilateral business relations between the United States and Germany. Representing more than 50% of the Life Sciences Markets in Europe, Germany offers a vivid network of innovative and mid-sized MedTech companies. MedNest works with the German American Chamber of Commerce to bridge innovative Medical Technology companies to the US markets.
Overview: OSEO was born in 2005, by bringing together ANVAR (French innovation agency) and BDPME (SME development bank) Its mission is to provide assistance and financial support to innovative French SMEs in the most decisive phases of their life cycle : start up, innovation, development, business transfer / buy out and international expansion. By sharing the risk, it facilitates the access of SMEs to financing by banking partners and equity capital investors MedNest has executed several "calibration" projects for Medical Technology Companies funded and supported by OSEO in their international expansion.
American Society of Clinical Oncology
Overview: The American Society of Clinical Oncology (ASCO) is the world?s leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals MedNest and several of it's Medical Advisors are active members of ASCO.
Hodgson Russ, LLP
Company Overview: Hodgson Russís approximately 200 attorneys provide business-focused U.S. legal counsel to clients in the United States, Canada, and across the world. Hodgson Russ practices in virtually every substantive area of law and generally use multidisciplinary work teams to serve the diverse and often complex needs of our clients.
MedNest and Hodson Russ combine their respective experience to provide our clients with even greater value and higher-quality service, innovative legal representation with a commitment to understanding our client's business, matching the right team of professionals to every matter.
With roots tracing back to 1817, Hodgson Russ is one of the nationís oldest law firms. The firm has offices in New York City, Albany, Buffalo, and Johnstown, New York; Palm Beach, Florida; and Toronto, Ontario.
Drug Information Association
Overview: DIA is a professional association of more than 18,000 members worldwide who are involved in discovery, development, regulation, surveillance, or marketing of biopharmaceutical products. DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well being worldwide. MedNest and several of its Industry Advisors are Active Members of DIA.
Natixis Pramex International
Company Overview: Natixis Pramex International supports and advises companies on their international strategy, from importation to exportation, the identification of local partners and setting up a local entity.
MedNest contribution: MedNest supports Natixis Pramex in the USA in the area of Healthcare Services and Medical Technology, with projects ranging from deal sourcing to the identification of distributors and partners in very specialised segments of the US MedTech and Healthcare sectors.
Founded in 1994, BioNJ has been hard at work in its mission to enhance the climate for Life Sciences in the State of New Jersey. As the representative of an industry that has the potential to change the course of human health, make our environment cleaner and the foods we eat safer and healthier, BioNJ is single-minded in its commitment to the growth and prosperity of this industry within the State of New Jersey.
MedNest and 10 of it's clients are amongst the first international Members of BIONJ. MedNest is committed to support BioNJ as a Platinum Member and be a catalyst for international Life Sciences companies to collocate with the Entrepreneurial Ecosystem of New Jersey.
Overview: Bio-1's goal is to make Central New Jersey the next "hot spot" for the global bioscience industry, by creating high-quality, high-paying jobs and a skilled workforce. MedNest and Bio-1 are collaborating on very specific international projects that will result in the collocation of numerous Life Science Companies in New Jersey and the development of a International Workforce in the State of NJ.